Efficacy of Intra-Articular Ketorolac and Bupivacaine on Postoperative Pain Relief after Arthroscopic Anterior Cruciate Ligament Reconstruction: A Randomized Double-Blind Study

Author:

Sathonphanit Supahsak,Thani Sakda,Thanomsingh Pachin

Abstract

Purpose: The purpose of our study was to determine whether there is any additional benefit to adding ketorolac, a non-steroidal anti-inflammatory drug (NSAID), to bupivacaine compared to bupivacaine alone in patients undergoing anterior cruciate ligament reconstruction (ACLR) surgery. Methods: Fifty-two American Society of Anesthesiology I-II patients undergoing arthroscopic ACLR under spinal anesthesia were randomly assigned to one of two groups: group A (10 mL of bupivacaine 0.25% with ketorolac 60 mg) and group B (10 mL of bupivacaine 0.25%). At the end of the procedure, 10 mL of each drug was administered intra-articularly. The dose of intravenously administered analgesic medication (morphine) was calculated based on the patient's body weight and visual analog scale (VAS) score. The postoperative time to rescue analgesia, 24-hour analgesic requirement, VAS score at time of rescue (T-rescue), and findings at rest and during movement were observed. Results: The VAS score at the time of rescue analgesic significantly lower in group A than in group B (33.85 ±19.61 ; 56.15±21.92) (p < 0.001). Group A had significantly lower 24-hour analgesic consumption than group B (0.28±0.07 ; 0.39±0.09) (p < 0.001).the mean duration of analgesia was longer in group A than in group B (320 minutes ; 235 minutes )(p = 0.194) however, this difference was not statistically significant. Conclusions: Intra-articular administration of a combination of ketorolac and bupivacaine resulted in a significantly longer duration of analgesia and reduced morphine use in the 24-hour postoperative period and is an effective option for reducing postoperative pain.

Publisher

The Royal College of Orthopaedic Surgeons of Thailand

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3